TOKYO, February 9, 2023 – Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., “Astellas”) today announced its commitment to achieve net zero greenhouse gas (GHG) emissions by 2050.
Astellas is committed to reducing greenhouse gas emissions in Scopes 1, 2, and 3*1 by 90% and neutralizing the remaining 10% of emissions by 2050*2, based on the 2015 level. Astellas has received accreditation from the Science Based Targets initiative (SBTi) for its 2030 GHG emission reduction targets.
"As outlined in our Corporate Strategic Plan 2021, our goal is to 'deepen our engagement in sustainability' and reducing our environmental impact is one of the key issues for Astellas,” said Kenji Yasukawa, President and CEO of Astellas. “As a responsible member of society, we are committed to GHG reduction efforts to achieve a sustainable society."
For more information on Astellas’ environmental efforts, please visit our website.
Astellas continues to further promote sustainability activities and expand information disclosure under its basic policy, which is to improve the sustainability of both the global society and Astellas while keeping ESG [environmental (E), social (S), governance (G)] in mind.
Click below for a copy of the full press release
